HLA-associated susceptibility to Type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study

Diabetologia

Volumn 36, Issue 3, 1993, Pages 234-238

  Rich, S S ^a   French, L R ^a   Sprafka, J M ^a   Clements, J P ^a   Goetz, F C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Genetics; HLA; Type 2 (non insulin dependent) diabetes mellitus

Indexed keywords

HLA DR4 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETICS; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DISEASE SUSCEPTIBILITY; FEMALE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HUMAN; MALE; MIDDLE AGE; MINNESOTA; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027526457     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00399956     Document Type: Article

References (21)

1. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins
2. Empirical risk for insulin-dependent diabetes (IDD) in sibs. Further definition of genetic heterogeneity
3. The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM
4. Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin
5. A population-based study of impaired glucose tolerance and type II diabetes: the Wadena City Health Study
6. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 yr
7. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
8. Genetic heterogeneity of diabetes and HLA
9. Classification and diagnostic criteria for diabetes and other categories of glucose intolerance
10. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT)
11. HL-A antigens and diabetes mellitus
12. Gene dosage and susceptibility to insulin-dependent diabetes
13. Mapping genes in diabetes: a genetic epidemiological perspective
14. Increased levels of acute-phase serum proteins in diabetes
15. Increased frequency of HLA-Cw4 in type 2 diabetes
16. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes
17. Relationship of prevalence of non-insulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas
18. Association between NIDDM, Rh blood group, and haptoglobin phenotype. Results from the San Antonio Heart Study
19. Genetic studies of type 2 (non-insulin-dependent) diabetes mellitus: lack of association with seven genetic markers